Showing results (291-300 of 783) with videos related to
Sort By:
Pageof 79
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1992
Therapy with monoclonal antibodies. An in vivo model for the assessment of therapeutic potentialJ D Isaacs, M R Clark, J Greenwood, et al.International Reviews of Immunology|March 5, 2010
Development of dendritic cell-based immunotherapy for autoimmunityCatharien M U Hilkens, John D Isaacs, Angus W ThomsonThe Lancet. Rheumatology|January 27, 2024
Biomarkers of tolerance in immune-mediated inflammatory diseases: a new era in clinical management?Kenneth F Baker, Jasmine P X Sim, John D IsaacsAlzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Cut-points and gray zones: The challenges of integrating Alzheimer's disease plasma biomarkers into clinical practiceJemma Hazan, Kathy Y Liu, Jeremy D Isaacs, et al.The Journal of Biological Chemistry|May 10, 1981
Internalization and degradation of thrombin and up regulation of thrombin-binding sites in corneal endothelial cellsN Savion, J D Isaacs, D Gospodarowicz, et al.Tissue Antigens|September 1, 1989
HLA class I antigens in severe RSV bronchiolitisD Isaacs, C J Taylor, A Ting, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1987
Cystic hydatid disease in Auckland, New Zealand, 1967-1982R D Isaacs, N J Beeching, R B Ellis-PeglerAging & Mental Health|October 16, 2024
Dementia diagnosis rates and the impact of ethnicity, rurality and deprivationJemma Hazan, Kathy Y Liu, Jeremy D Isaacs, et al.Archives of Disease in Childhood|May 1, 1979
A year's experience of the rotavirus syndrome and its association with respiratory illnessH M Lewis, J V Parry, H A Davies, et al.British Journal of Cancer|August 18, 2005
REporting recommendations for tumour MARKer prognostic studies (REMARK)L M McShane, D G Altman, W Sauerbrei, et al.Pageof 79